trending Market Intelligence /marketintelligence/en/news-insights/trending/G0BDIN-DkJE5_jOC33LOjw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

AMS Life Science fiscal Q3 profit climbs 96.3% YOY

The Evolution Of ESG Factors In Credit Risk Assessment: Corporate Governance

Industry Top Trends 2021: Metals and Mining

TMT News & Research: 2020 Recap

Banking Essentials Newsletter - January Edition

AMS Life Science fiscal Q3 profit climbs 96.3% YOY

AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal third quarter ended May 31 came to ¥12.16 per share, an increase of 96.2% from ¥6.20 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥147.3 million, an increase of 96.3% from ¥75.0 million in the year-earlier period.

The normalized profit margin climbed to 4.2% from 2.1% in the year-earlier period.

Total revenue totaled ¥3.50 billion, compared with ¥3.54 billion in the year-earlier period, and total operating expenses decreased on an annual basis to ¥3.25 billion from ¥3.40 billion.

Reported net income increased year over year to ¥181.7 million, or ¥15.00 per share, from ¥73.1 million, or ¥6.04 per share.

As of July 15, US$1 was equivalent to ¥123.95.